Utility of SCORE2 risk algorithm for predicting life course accelerated frailty and physical function decline-Reference-Cited by-同舟云学术

Utility of SCORE2 risk algorithm for predicting life course accelerated frailty and physical function decline

Published:2022-12-26 Issue:1 Volume:14 Page:596-605
ISSN:2190-5991
Container-title:Journal of Cachexia, Sarcopenia and Muscle
language:en
Short-container-title:J cachexia sarcopenia muscle

Author:

Li Chenglong¹²^ORCID,Ma Yanjun¹²,Hua Rong¹²,Zheng Fanfan³,Xie Wuxiang¹²

Affiliation:

1. Peking University Clinical Research Institute Peking University First Hospital Beijing China

2. PUCRI Heart and Vascular Health Research Center Peking University, Shougang Hospital Beijing China

3. School of Nursing, Peking Union Medical College Chinese Academy of Medical Sciences Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Physiology (medical),Orthopedics and Sports Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcsm.13165

Reference31 articles.

1. Frailty: implications for clinical practice and public health

2. Frailty index and all-cause and cause-specific mortality in Chinese adults: a prospective cohort study

3. Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Association for Acute Cardio Vascular Care (ACVC), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart Diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular Diseases, WG e-Cardiology, WG Thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS)

4. Interventions to prevent or reduce the level of frailty in community‐dwelling older adults: a scoping review of the literature and international policies;Puts MTE;Age Ageing,2017

5. Treatment Strategies for Sarcopenia and Frailty